The MOVE on Mycoses live CME/CE programs were developed to meet the educational needs of physicians, nurses, pharmacists and other health care professionals who care for immunosuppressed patients, work in the field of transplantation, or are responsible for seriously ill, hospitalized patients, especially those in the ICU. Each meeting featured a presentation by a leading expert in fungal infections followed by a question and answer session, where a regional expert joined the discussion. While the faculty presenters lent their expertise based on a broader, national level, the local clinicians were able provide insight into regional issues that are associated with the management and treatment of IFIs. These programs were planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME), ACPE, and ANCC.

For overall planning faculty, click here to meet the Fungal Affairs Council.

The program faculty consisted of nationally esteemed experts in the area of infectious diseases:

The program moderators were local experts in invasive fungal infections:

• Etiology and epidemiology of invasive fungal infections including the identification of important risk factors
• Prophylaxis, diagnosis and treatment of invasive fungal infections
• Pharmacological considerations in the selection of antifungal agents

This activity was designed to meet the needs of physicians, pharmacists, nurses, and all healthcare professional who care for and who may be involved in the diagnosis, management, and treatment of invasive fungal infections.

The American Academy of CME provided certification for physicians, pharmacists, and nurses. If you attended a meeting and submitted your CME/CE materials but have not yet received credit, please contact the Academy directly.

At the conclusion of each program, participants were better able to:

• Define risk factors associated with specific fungal pathogens likely to cause clinically significant infections in high-risk patients
• Recognize the barriers to timely diagnosis of invasive fungal infections (IFIs)
• Assess the current evidence for appropriate prophylaxis and empiric therapeutic strategies in the treatment of IFIs
• Evaluate the best evidence for the treatment of proven IFIs
• Explain the issues related to the selection of appropriate antifungal therapy including toxicities and relevant drug-drug interactions with concomitant therapies

Of those who filled out the evaluation forms, 88% rated the overall clinical relevance of the program as 'Excellent' or 'Good.' Thirty-six percent indicated that they would change patient care based on what they had learned during the program. When asked to what extent they were committed to implementing this change, 96% responded either 'Very committed' or 'Committed.' When asked how they intended to modify their practice performance, MOVE attendees had many responses, with the most common being:

• Encourage treatment without delay
• Work with the lab to isolate cause of infection
• Apply information about the susceptibility of various agents

One question on the evaluation form was "What barriers outside of your control have an impact on patient outcomes?" Respondents were asked to review a list of potential barriers and check all that applied. Here are the results:

Participants were asked to identify what CE/CME topics represent their highest learning priority. Responses to this question were quite varied and were not restricted to the therapeutic area of infectious diseases. More pharmacist and physician attendees listed MRSA, community-acquired MRSA, and the epidemiology of community-acquired infections as their primary area of educational interest than any other category or therapeutic area.

We are pleased to offer you an extensive slide library set that was employed in this education activity and includes the latest information on all aspects of invasive fungal infections. To download a PDF of any of these slide libraries, please click on the icons below.

We are extremely pleased to share this Report Back to the Audience with you and hope that it has served you well. If you have any feedback or would like to receive future cumulative reports, we would like to hear from you. Also, if you have any suggestions or requests for educational activities in the area of infectious diseases or any other therapeutic area, please let us know. You can e-mail us at info@moveonmycoses.com. We are always interested in the following:

• Topics for new educational activities
• New educational approaches
• Preferred methods for receiving education